Home > News > Local business cooperates with WU on nanotechnology
October 9th, 2006
Local business cooperates with WU on nanotechnology
Abstract:
Washington University researchers Gregory Lanza and Samuel Wickline partnered with Kereos, a local St. Louis company, to develop treatments for cancer and blocked arteries using nanotechnology. The original discovery licensed to Kereos involves the use of nanoparticles approximately one-billionth of a meter in size for imaging and targeting drug delivery.
Source:
studlife.com
Bookmark:
| Related Links |
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||